All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
XBI real return snapshot: after CPI-U inflation, XBI returned +70.80% over the past year and +25.25% YTD, with dividends reinvested. Since Feb. 6, 2006, XBI is up +502.04% in real purchasing-power return, or +9.14%/yr, and is currently −28.64% below its real total-return high on Feb. 8, 2021.
Data ending Fri Aug. 14, 2026
| Mon 2006-02-06💬 to Fri 2026-08-14 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| XBI × |
+502.04%
+9.14%/yr |
+9.80%/yr
R2=0.759 |
||||
| SPDR S&P Biotech ETF Exchange-Traded Fund | ||||||
| Mon 2006-02-06💬 to Fri 2026-08-14 |
Start
Value |
End
Value |
|---|---|---|
| XBI × |
$10,000.00
2006-02-06 |
$60,204.16
2026-08-14 |
| YTD | YoY | |
|---|---|---|
| XBI × | +25.25% | +70.80% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| XBI × |
−28.64%
on 2026-08-14 from 2021-02-08 peak |
−68.61%
on 2023-10-27 from 2021-02-08 peak |
| Period ending Fri 2026-08-14 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| XBI × | +70.80% |
+54.93% +24.47%/yr |
+81.33% +21.94%/yr |
+3.88% +0.77%/yr |
+83.90% +6.28%/yr |
| Year | XBI |
|---|---|
| 2026 (YTD) | +25.25% |
| 2025 | +32.35% |
| 2024 | −1.82% |
| 2023 | +4.11% |
| 2022 | −30.37% |
| 2021 | −25.68% |
| 2020 | +46.34% |
| 2019 | +29.60% |
| 2018 | −16.86% |
| 2017 | +40.80% |
| 2016 | −17.16% |
| 2015 | +12.75% |
| 2014 | +43.89% |
| 2013 | +46.19% |
| 2012 | +30.43% |
| 2011 | +2.23% |
| 2010 | +15.87% |
| 2009 | −2.30% |
| 2008 | −8.65% |
| 2007 | +23.96% |
| 2006 | −7.89% |
